CASI - CASI Pharmaceuticals GAAP EPS of -$0.27 beats by $0.03 revenue of $30.17M beats by $0.09M
CASI Pharmaceuticals press release (NASDAQ:CASI): FY GAAP EPS of -$0.27 beats by $0.03. Revenue of $30.17M (+99.3% Y/Y) beats by $0.09M.
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.27 beats by $0.03, revenue of $30.17M beats by $0.09M